4//SEC Filing
KUCHARCHUK ANDREW ALBERT 4
Accession 0001493152-20-010889
CIK 0001362703other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 9:33 PM ET
Size
6.0 KB
Accession
0001493152-20-010889
Insider Transaction Report
Form 4
KUCHARCHUK ANDREW ALBERT
DirectorCFO & President
Transactions
- Award
Series D-2 Convertible Preferred Stock
2020-06-05+241→ 241 totalExercise: $0.00→ Common Stock (2,410,000 underlying)
Footnotes (3)
- [F1]The Series D-2 Convertible Preferred Stock will automatically convert into shares of Common Stock upon the filing of an amendment to the Issuer's Articles of Incorporation with the Secretary of State of the State of Nevada to increase the number of shares of Common Stock the Issuer is authorized to issue.
- [F2]The Series D-2 Convertible Preferred has no expiration date.
- [F3]No additional consideration need be paid for the automatic conversion to common stock to take place.
Documents
Issuer
OncBioMune Pharmaceuticals, Inc
CIK 0001362703
Entity typeother
Related Parties
1- filerCIK 0001654127
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 9:33 PM ET
- Size
- 6.0 KB